Naproxen reduces tumors in a mouse model of colon cancer, researchers report
Links shared publicly online about this topic.
- 373total visits
Naproxen reduces tumors in a mouse model of colon cancer, researchers report
Numerous studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colon cancer. However, animal studies testing the NSAID naproxen or its derivative, NO-naproxen, have focused primarily on chemically-induced tumor formation. Now, researchers find that naproxen and NO-naproxen reduce tumor formation in a strain of mutant mice that spontaneously develop colon tumors. The data also suggest that naproxen blocks a gatekeeper step that initiates tumor formation.
View full resource at sciencedaily.com
Tags: Digestion, Cancer, Colon Cancer, Arthritis Medication, Drug, Naprosyn, Aleve, Midol Extended Relief
Most Recently Shared on April 11, 2011 at 3:20 pm By:
Naproxen reduces tumors in a mouse model of colon cancer, researchers report http://bit.ly/hbgmBX
Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer
physorg.com — “Numerous studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colon cancer. However, animal studies testing the NSAID naproxen or its derivative, NO-naproxen, have focused primarily on chemically-induced tumor formation. Now, researchers at Fox Chase Cancer Center find ...” View full resource at physorg.com
Most Recently Shared on April 6, 2011 at 12:41 pm By:
Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer http://bit.ly/fNB2yO
Advertisement
